86-21-64556180 ib

FLT3

CAT # Khoom npe Kev piav qhia
PAB 0099 Quizartinib; AC-010220; AC-220 Quizartinib yog ib qho inhibitor ntawm FMS-txog tyrosine kinase 3 (FLT3; Kd = 1.6 nM) thiab ua kom pom kev xaiv siab rau FLT3 thaum kuaj tawm tsam ntawm 227 kinases ntxiv. Nws inhibits qhov kev loj hlob ntawm tib neeg leukemia cell kab MV4-11, uas harbors ib homozygous FLT3-ITD kev hloov, nrog rau IC50 tus nqi ntawm 0.56 nM.1 Ntawm 1 mg / kg / hnub, quizartinib tau pom tias kom muaj sia nyob ntev hauv nas. Tus qauv ntawm FLT3-ITD mob myeloid leukemia thiab tshem tawm cov qog hauv ib qho FLT3-dependent nas xenograft qauv ntawm 10 mg/kg.
ua

Tiv tauj peb

Kev nug

Xov xwm tshiab

  • Sab saum toj 7 trends hauv Pharmaceutical Research Hauv 2018

    Sab saum toj 7 Trends Hauv Pharmaceutical Research Kuv ...

    Nyob rau hauv ib txwm muaj-nce siab los sib tw nyob rau hauv ib tug nyuaj kev lag luam thiab thev naus laus zis ib puag ncig, kws tshuaj thiab biotech tuam txhab uas muag yuav tsum txuas ntxiv innovate nyob rau hauv lawv cov R & D cov kev pab cuam nyob rau hauv ...

  • ARS-1620: Kev cog lus tshiab inhibitor rau KRAS-mutant qog noj ntshav

    ARS-1620: Kev cog lus tshiab inhibitor rau K ...

    Raws li kev tshawb fawb luam tawm hauv Cell, cov kws tshawb fawb tau tsim ib qho inhibitor tshwj xeeb rau KRASG12C hu ua ARS-1602 uas ua rau cov qog nqaij hlav hauv cov nas. "Qhov kev tshawb fawb no muab pov thawj hauv vivo tias mutant KRAS tuaj yeem yog ...

  • AstraZeneca tau txais kev tswj hwm kev txhawb nqa rau cov tshuaj oncology

    AstraZeneca tau txais kev tswj hwm kev txhawb nqa rau ...

    AstraZeneca tau txais kev txhawb nqa ob npaug rau nws cov ntaub ntawv kho mob oncology rau hnub Tuesday, tom qab Asmeskas thiab European cov neeg tswj hwm tau txais kev tswj hwm kev xa tawm rau nws cov tshuaj, thawj kauj ruam ntawm kev pom zoo rau cov tshuaj no. ...

WhatsApp pawg online sib tham!